These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17873609)

  • 21. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
    Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH
    Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Portal hypertension in primary biliary cirrhosis: a potentially reversible harbinger of demise.
    Mayo MJ
    Gastroenterology; 2008 Nov; 135(5):1450-1. PubMed ID: 18848554
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate.
    Lee YM; Kaplan MM
    Am J Gastroenterol; 2003 Jan; 98(1):205-8. PubMed ID: 12526960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis.
    Gómez-Dominguez E; Mendoza J; García-Buey L; Trapero M; Gisbert JP; Jones EA; Moreno-Otero R
    Aliment Pharmacol Ther; 2008 Mar; 27(5):441-7. PubMed ID: 18081731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.
    Al-Chalabi T; Portmann BC; Bernal W; McFarlane IG; Heneghan MA
    Aliment Pharmacol Ther; 2008 Jul; 28(2):209-20. PubMed ID: 18433467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
    Silveira MG; Lindor KD
    Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and management of primary biliary cirrhosis.
    Ali AH; Carey EJ; Lindor KD
    Expert Rev Clin Immunol; 2014 Dec; 10(12):1667-78. PubMed ID: 25382237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
    Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
    Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
    Chan CW; Gunsar F; Feudjo M; Rigamonti C; Vlachogiannakos J; Carpenter JR; Burroughs AK
    Aliment Pharmacol Ther; 2005 Feb; 21(3):217-26. PubMed ID: 15691295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of autoimmune liver disease in Alaska Natives.
    Hurlburt KJ; McMahon BJ; Deubner H; Hsu-Trawinski B; Williams JL; Kowdley KV
    Am J Gastroenterol; 2002 Sep; 97(9):2402-7. PubMed ID: 12358264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Primary biliary cirrhosis].
    Kuiper EM; den Ouden-Muller JW; van Buuren HR
    Ned Tijdschr Geneeskd; 2009; 153():A483. PubMed ID: 19900324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and clinical course of primary biliary cholangitis in Eastern Slovakia.
    Drazilova S; Babinska I; Gazda J; Halanova M; Janicko M; Kucinsky B; Safcak D; Martinkova D; Tarbajova L; Cekanova A; Jarcuska P;
    Int J Public Health; 2020 Jun; 65(5):683-691. PubMed ID: 32500239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients.
    ter Borg PC; Schalm SW; Hansen BE; van Buuren HR;
    Am J Gastroenterol; 2006 Sep; 101(9):2044-50. PubMed ID: 16848809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis.
    Guañabens N; Parés A; Ros I; Caballería L; Pons F; Vidal S; Monegal A; Peris P; Rodés J
    J Hepatol; 2005 Apr; 42(4):573-7. PubMed ID: 15763344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epidemiology of primary biliary cirrhosis in north-east England: an increasingly common disease?
    Myszor M; James OF
    Q J Med; 1990 Apr; 75(276):377-85. PubMed ID: 2385742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation trends in primary biliary cirrhosis.
    Lee J; Belanger A; Doucette JT; Stanca C; Friedman S; Bach N
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1313-5. PubMed ID: 17900996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varices in early histological stage primary biliary cirrhosis.
    Ali AH; Sinakos E; Silveira MG; Jorgensen RA; Angulo P; Lindor KD
    J Clin Gastroenterol; 2011 Aug; 45(7):e66-71. PubMed ID: 20856137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Primary biliary cirrhosis].
    Chon CY; Park JY
    Korean J Hepatol; 2006 Sep; 12(3):364-72. PubMed ID: 16998288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and longterm course of primary biliary cirrhosis in primary Sjögren's syndrome.
    Hatzis GS; Fragoulis GE; Karatzaferis A; Delladetsima I; Barbatis C; Moutsopoulos HM
    J Rheumatol; 2008 Oct; 35(10):2012-6. PubMed ID: 18709690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.